Ginkgo Bioworks Holdings reports Q4 results
Source: SeekingAlpha
2026-02-27 11:37:24 ET
More on Ginkgo Bioworks Holdings
- Ginkgo Bioworks Holdings, Inc. (DNA) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Ginkgo Bioworks Holdings, Inc. (DNA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Ginkgo - OpenAI collaboration cuts costs in protein synthesis
- Seeking Alpha’s Quant Rating on Ginkgo Bioworks Holdings
- Historical earnings data for Ginkgo Bioworks Holdings
Read the full article on Seeking Alpha
For further details see:
Ginkgo Bioworks Holdings reports Q4 results
Ginkgo Bioworks Holdings Inc. Class A
NASDAQ: DNA
DNA Trading
3.09% G/L:
$6.67 Last:
307,571 Volume:
$6.53 Open:
DNA Latest News
March 02, 2026 08:00:00 am
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure
February 26, 2026 04:26:00 pm
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business
February 19, 2026 08:00:00 am
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation
DNA Stock Data
$559,247,721
48,775,126
0.01%
64
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
